Pharmaceutical

Pharmacy Benefit Managers: Driving Cost Savings and Innovation in Healthcare

Real value in working with Canada Drugs Direct as a partner pharmacy that is able to serve as a PBM…

2 weeks ago

Rapid Dose Announces Proposed Equity Private Placement Financing and Proposed Shares for Debt Settlement

Burlington, Ontario--(Newsfile Corp. - December 10, 2024) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT" or the "Company") today announced that…

2 weeks ago

Healthier Capital Led by Former One Medical CEO Invests in Hyro’s Responsible AI Agents for Healthcare

New growth capital, taking total raised by Hyro to $50 million, will advance leading conversational and generative AI solutions across…

2 weeks ago

Dotmatics and Databricks Partner to Advance Scientific Intelligence in Life Sciences

The strategic partnership combines Dotmatics' deep expertise in scientific software with Databricks data intelligence expertise An upcoming webinar with Databricks…

2 weeks ago

Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN

Admission of New Ordinary Shares and New ISIN LONDON, UNITED KINGDOM / ACCESSWIRE / December 10, 2024 / Hemogenyx Pharmaceuticals…

2 weeks ago

MIRA Pharmaceuticals Validates Ketamir-2’s Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End

Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain MIAMI, FL / ACCESSWIRE /…

2 weeks ago

Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product

~ Supply Chain Now Fully Secure for PF614-MPAR ~ SAN DIEGO, CA / ACCESSWIRE / December 10, 2024 / Ensysce…

2 weeks ago

Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)

TORONTO, ON / ACCESSWIRE / December 10, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical…

2 weeks ago

VisiRose Introduces Revolutionary Therapy for Severe Eye Infections

Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals KNOXVILLE, TN / ACCESSWIRE / December 10, 2024 / VisiRose, a…

2 weeks ago

Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide in people with overweight or obesity

Press Release – No. 12 / 2024 Zealand Pharma announces first participant enrolled in Phase 2b ZUPREME-1 trial of petrelintide…

2 weeks ago